Dr Lal PathLabs will announce its Q3 results for FY25 on January 30, 2025. The Board of Directors will also discuss a third ...

The company secured new total contract value (TCV) wins worth  $351 million in its direct business during Q3FY25. Reported operating margin stood at 15.3%.

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships in 2025. Click for this ARQT update.

Capri Global Capital reported a strong Q3 performance with a net profit of ₹108 crore, marking a 111% YoY increase from ₹51.3 crore.

Adani Power announced its board will meet on January 29, 2025, to approve Q3 financial results for the quarter and nine ...

Limited (WNS) (NYSE: WNS), a digital-led business transformation and services partner, today announced results for the fiscal 2025 ...

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look ...

KFin Technologies Ltd on Thursday reported a 35 per cent year-on-year surge in profit after tax to Rs 90.18 crore for three ...

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look ...

The microfinance institution Spandana Sphoorty Financial Ltd (SSFL) posted a significant loss of Rs 440 crore in the third ...

MakeMyTrip posted a Q3 FY25 profit of $27M, up from $24M last year, with revenues rising 26.2% to $267.4M. Strong growth in gross bookings, international outbound, and operating profit drove ...

United Spirits posted revenue from operations at Rs 7,732 crore, reporting a growth of 11.06 per cent as against Rs 6,962 crore during the third quarter of FY24.